These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23197158)

  • 1. Urotensin II and the kidney.
    Langham RG; Kelly DJ
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):107-12. PubMed ID: 23197158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin II: a cardiovascular and renal update.
    Zoccali C; Mallamaci F
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of urotensin II in human pathophysiology].
    Piech J; Skoczylas A
    Wiad Lek; 2008; 61(10-12):277-82. PubMed ID: 19323069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor.
    Yoshimoto T; Matsushita M; Hirata Y
    Peptides; 2004 Oct; 25(10):1775-81. PubMed ID: 15476945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urotensin II--new peptide which regulates function of cardiovascular system].
    Jołda-Mydłowska B
    Pol Merkur Lekarski; 2004 May; 16(95):474-6. PubMed ID: 15518431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese.
    Suzuki S; Wenyi Z; Hirai M; Hinokio Y; Suzuki C; Yamada T; Yoshizumi S; Suzuki M; Tanizawa Y; Matsutani A; Oka Y
    Peptides; 2004 Oct; 25(10):1803-8. PubMed ID: 15476949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?
    Giachini FR; Callera GE; Carneiro FS; Tostes RC; Webb RC
    Expert Opin Ther Targets; 2008 Mar; 12(3):327-39. PubMed ID: 18269342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of four urotensin II receptors (UTS2Rs) in chickens.
    Cui L; Lv C; Zhang J; Li J; Wang Y
    Peptides; 2021 Apr; 138():170482. PubMed ID: 33359825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems.
    Takahashi K; Hirose T; Mori N; Morimoto R; Kohzuki M; Imai Y; Totsune K
    Peptides; 2009 Aug; 30(8):1575-85. PubMed ID: 19477209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urotensin-II and cardiovascular remodeling.
    Papadopoulos P; Bousette N; Giaid A
    Peptides; 2008 May; 29(5):764-9. PubMed ID: 17988761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urotensin II: a new pharmacologic target in the treatment of cardiovascular disease.
    Desai N; Sajjad J; Frishman WH
    Cardiol Rev; 2008; 16(3):142-53. PubMed ID: 18414185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin II: lessons from comparative studies for general endocrinology.
    Lu W; Abdel-Razik AE; Ashton N; Balment RJ
    Gen Comp Endocrinol; 2008 May; 157(1):14-20. PubMed ID: 18440535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles of urotensin-II in cardiovascular disease.
    Russell FD
    Pharmacol Ther; 2004 Sep; 103(3):223-43. PubMed ID: 15464591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease.
    Gilbert RE; Douglas SA; Krum H
    Curr Opin Investig Drugs; 2004 Mar; 5(3):276-82. PubMed ID: 15083593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Classic Adrenal Secretagogues on mRNA Levels of Urotensin II and Its Receptor in Adrenal Gland of Rats.
    Jopek K; Tyczewska M; Szyszka M; Blatkiewicz M; Jopek M; Malendowicz LK; Ruciński M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II: the old kid in town.
    Onan D; Hannan RD; Thomas WG
    Trends Endocrinol Metab; 2004; 15(4):175-82. PubMed ID: 15109617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urotensin II: biological action on the kidney].
    Satoh F; Ito S
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():719-21. PubMed ID: 15506481
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of urotensin II in the metabolic syndrome.
    Ong KL; Wong LY; Cheung BM
    Peptides; 2008 May; 29(5):859-67. PubMed ID: 17610998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of urotensin II in atherosclerotic cardiovascular diseases.
    Pakala R
    Cardiovasc Revasc Med; 2008; 9(3):166-78. PubMed ID: 18606380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of new pharmacophores for nonpeptide antagonists of human urotensin-II. Comparison with the 3D-structure of human urotensin-II and URP.
    Lescot E; Sopkova-de Oliveira Santos J; Dubessy C; Oulyadi H; Lesnard A; Vaudry H; Bureau R; Rault S
    J Chem Inf Model; 2007; 47(2):602-12. PubMed ID: 17381176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.